Alternating Treatment With Pazopanib and Everolimus vs Continuous Pazopanib to Delay Disease Progression in Patients With Metastatic Clear Cell Renal Cell Cancer: The ROPETAR Randomized Clinical Trial.

Autor: Cirkel, Geert A., Hamberg, Paul, Sleijfer, Stefan, Loosveld, Olaf J. L., Dercksen, M. Wouter, Los, Maartje, Polee, Marco B., van den Berkmortel, Franchette, Aarts, Maureen J., Beerepoot, Laurens V., Groenewegen, Gerard, Lolkema, Martijn P., Tascilar, Metin, Portielje, Johanna E. A., Peters, Frank P. J., Klümpen, Heinz-Josef, van der Noort, Vincent, Haanen, John B. A. G., Voest, Emile E.
Zdroj: JAMA Oncology; Apr2017, Vol. 3 Issue 4, p501-508, 8p
Databáze: Complementary Index